Cite

HARVARD Citation

    Desjardins, A. et al. (2021). IMMU-26. SAFETY AND EFFICACY OF PVSRIPO IN RECURRENT GLIOBLASTOMA: LONG-TERM FOLLOW-UP AND INITIAL MULTICENTER RESULTS. Neuro-oncology. p. vi97. [Online]. 
  
Back to record